GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuyu Pharma Inc (XKRX:000220) » Definitions » Research & Development

Yuyu Pharma (XKRX:000220) Research & Development : ₩7,188 Mil (TTM As of Dec. 2023)


View and export this data going back to 1975. Start your Free Trial

What is Yuyu Pharma Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Yuyu Pharma's Research & Development for the three months ended in Dec. 2023 was ₩766 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩7,188 Mil.


Yuyu Pharma Research & Development Historical Data

The historical data trend for Yuyu Pharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuyu Pharma Research & Development Chart

Yuyu Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 876.67 4,122.66 4,008.28 8,620.37 7,187.64

Yuyu Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,639.37 2,617.63 2,601.50 1,202.08 766.42

Yuyu Pharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,188 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yuyu Pharma  (XKRX:000220) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Yuyu Pharma Research & Development Related Terms

Thank you for viewing the detailed overview of Yuyu Pharma's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Yuyu Pharma (XKRX:000220) Business Description

Traded in Other Exchanges
Address
197, Dongho-ro, Yuyu Building, Jung-gu, Seoul, KOR
Yuyu Pharma Inc. manufactures and markets medicines. The major product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.

Yuyu Pharma (XKRX:000220) Headlines

No Headlines